Filing Flows › Whitehawk Therapeutics (WHWK) › Next earnings date
Whitehawk Therapeutics (WHWK) earnings on Nov 9, 2026: what to expect
Whitehawk Therapeutics (WHWK) is expected to report earnings on Nov 9, 2026 (estimated), tomorrow, for the quarter ending Sep 30, 2026. Analysts expect EPS of −$0.24 (−$0.27 to −$0.21, 4 estimates), against −$0.25 a year ago. It beat the EPS estimate in 50% of the quarters on record; Filing Flows' model gives it a 65% chance of beating next time.
What to watch
Last quarter (Q1 2025) the lines that make up revenue grew like this; the report shows whether the trend holds:
Filing Flows' own estimate from the SEC figures — the same quarter last year times recent growth — is EPS −$0.25, against the analysts' −$0.24.
The last report
Whitehawk Therapeutics reported revenue of $7.1M for the first quarter 2025 (+34% Y/Y), net earnings $73.0M. How it makes money → · Every quarter →
Whitehawk Therapeutics' latest quarter
Whitehawk Therapeutics, Q1 2025: revenue $7.1M (+34% year over year), operating margin -213.0%, net earnings $73.0M, operating cash flow −$11.9M. The chart follows the revenue to costs, profit and cash.
Questions
When does WHWK report earnings?
Whitehawk Therapeutics is expected to report on Nov 9, 2026 (estimated).
What are analysts expecting from Whitehawk Therapeutics?
EPS of −$0.24 for the quarter.
Does Whitehawk Therapeutics usually beat earnings?
It beat the consensus EPS estimate in 50% of the quarters on record.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.